Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial

Thrombosis and Haemostasis

Volumn 92, Issue 3, 2004, Pages 575-582

  Haire, William D ^a   Dietcher, Steven R ^b   Mullane, Kathleen M ^c   Jaff, Michael R ^d   Firszt, Carolyn M ^e   Schulz, Gregory A ^e   Schuerr, Debra M ^e   Schwartz, Lewis B ^e   Mouginis, Tamyra L ^e   Barton, R Phillip ^f  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d LENOX HILL HOSPITAL   (United States)

^e ABBOTT LABORATORIES   (United States)

^f Children's Hospital at Saint Francis   (United States)

Author keywords

Central venous catheter; Thrombolysis; Urokinase

Indexed keywords

PLACEBO; UROKINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD SAMPLING; BLOOD VESSEL OCCLUSION; CANADA; CENTRAL VENOUS CATHETERIZATION; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE REMOVAL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPOTHESIS; INCIDENCE; INFORMED CONSENT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECANALIZATION; SEPSIS; TREATMENT OUTCOME; UNITED STATES; VASCULAR ACCESS; VASCULAR PATENCY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; GRAFT OCCLUSION, VASCULAR; HEMORRHAGE; HUMANS; INFANT; KINETICS; MALE; MIDDLE AGED; PLACEBOS; RECOMBINANT PROTEINS; URINARY PLASMINOGEN ACTIVATOR;

EID: 4544363678     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH03-11-0686     Document Type: Article

References (20)

1. Maki DG, Stolz SM, Wheeler S, et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. Ann Int Med 1997; 127: 257-66.
2. Jacobs BR, Haygood M, Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr 2001; 139: 593-6.
3. Credo RB, Burke SE, Barker WM, et al. Recombinant urokinase (r-UK): Biochemistry, pharmacology, and clinical experience. New Ther Agents in Thromb & Thrombol 1997: 513-37.
4. Graafsma YP, Prins MH, Lensing WA, et al. Bleeding classification in clinical trials: observer variability and clinical relevance. Thromb Haemost 1997; 78: 1189-92.
5. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. New Engl J Med 1998; 338: 1105-11.
6. Daeihagh P, Jordan J, Chem J, et al. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis 2000; 36: 75-9.
7. Haire WD, Atkinson JB, Stephens LC, et al. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blind randomized trial. Thromb Haemost 1994; 72: 543-7.
8. Suhocki PV, Conion PJ, Knelson MH, et al. Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis 1996; 28: 379-86.
9. Schwab SJ, Buller GL, McCann RL, et al. Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use. Am J Kidney Dis 1988; 11: 166-9.
10. Deitcher SR, Fesen MR, Kiproff PM, et al. Safety and efficacy of alteplase for restoring function in occluded central venous catheters: Results of the Cardiovascular Thrombolytic to Open Occluded Lines Trial. J Clin Onc 2002; 20: 317-24.
11. Clase CM, Crowther MA, Ingram AJ, et al. Thrombolysis for restoration of patency to hemodialysis central venous catheters: A systematic review. J Throm Thrombolysis 2001; 11: 127-36.
12. Hurtubise MR, Bottino JC, Lawson M, et al. Restoring patency of occluded central venous catheters. Arch Surg 1980; 115: 212-13.
13. Glynn MF, Langer B, Jeejeebhoy KN. Therapy for thrombotic occlusion of long-term intravenous alimentation catheters. J Parenter Enteral Nutr 1980; 4: 387-90.
14. Lawson M, Bottino JC, Hurtubise MR, et al. The use of urokinase to restore the patency of occluded central venous catheters. Am J Intraven Ther Clin Nutr 1982; 9: 29-32.
15. Wachs T. Urokinase administration in pediatric patients with occluded central venous catheters. J Intraven Nurs 1980; 13: 100-2.
16. Northsea C. Using urokinase to restore patency in double lumen catheters. ANNA J 1994; 21: 261-4.
17. Moss AH, Vasilakis C, Holley JL, et al. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis 1990; 16: 211-5.
18. Bour ES, Weaver AS, Yang HC, et al. Experience with the double lumen Silastic catheter for hemoaccess. Surg Gynecol Obstet 1990; 171: 33-9.
19. Ponec D, Irwin D, Haire WD, et al. Recombinant tissue plasminogen activator (Alteplase) for restoration of flow in occluded central venous access devices: A double-blind placebo-controlled trial - The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Interv Radiol 2001; 12: 951-5.
20. Stephens LC, Haire WD, Kotulak GD. Are clinical signs accurate indicators of the cause of central venous catheter occlusion? JPEN J Parenter Enteral Nutr 1995; 19: 75-9.